Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group.

N Engl J Med. 2010 Jul 22;363(4):311-20. doi: 10.1056/NEJMoa1002853. Epub 2010 Jun 29. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092.

2.

Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.

Diabetes Care. 2010 May;33(5):1004-8. doi: 10.2337/dc09-2081. Epub 2010 Mar 3.

3.

Standards of medical care in diabetes--2010.

American Diabetes Association.

Diabetes Care. 2010 Jan;33 Suppl 1:S11-61. doi: 10.2337/dc10-S011. No abstract available. Erratum in: Diabetes Care. 2010 Mar;33(3):692.

4.

Hippocampal volumes in youth with type 1 diabetes.

Hershey T, Perantie DC, Wu J, Weaver PM, Black KJ, White NH.

Diabetes. 2010 Jan;59(1):236-41. doi: 10.2337/db09-1117. Epub 2009 Oct 15.

5.

Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV.

Diabetes Care. 2009 Nov;32(11):1947-53. doi: 10.2337/dc09-0889. Epub 2009 Aug 12.

6.

The effect of continuous glucose monitoring in well-controlled type 1 diabetes.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, Chase P, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Huang ES, Kollman C, Kowalski AJ, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer SA, Wilson DM, Wolpert H, Wysocki T, Xing D.

Diabetes Care. 2009 Aug;32(8):1378-83. doi: 10.2337/dc09-0108. Epub 2009 May 8.

7.

Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.

O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW, Davis EA, Cameron FJ.

Diabetologia. 2009 Jul;52(7):1250-7. doi: 10.1007/s00125-009-1365-0. Epub 2009 Apr 25.

PMID:
19396424
8.

Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: evidence from a clinical audit.

Smith CB, Choudhary P, Pernet A, Hopkins D, Amiel SA.

Diabetes Care. 2009 Jul;32(7):1196-8. doi: 10.2337/dc08-2259. Epub 2009 Apr 23.

9.

Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D.

N Engl J Med. 2008 Oct 2;359(14):1464-76. doi: 10.1056/NEJMoa0805017. Epub 2008 Sep 8.

10.

Cognitive function in children with type 1 diabetes: a meta-analysis.

Gaudieri PA, Chen R, Greer TF, Holmes CS.

Diabetes Care. 2008 Sep;31(9):1892-7. doi: 10.2337/dc07-2132.

11.

A1C in children and adolescents with diabetes in relation to certain clinical parameters: the Swedish Childhood Diabetes Registry SWEDIABKIDS.

Hanberger L, Samuelsson U, Lindblad B, Ludvigsson J; Swedish Childhood Diabetes Registry SWEDIABKIDS.

Diabetes Care. 2008 May;31(5):927-9. doi: 10.2337/dc07-1863. Epub 2008 Jan 30.

PMID:
18235047
12.

Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy.

Shalitin S, Phillip M.

Diabetes Care. 2008 Feb;31 Suppl 2:S121-4. doi: 10.2337/dc08-s228.

PMID:
18227471
13.

Long-term effect of diabetes and its treatment on cognitive function.

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J.

N Engl J Med. 2007 May 3;356(18):1842-52. Erratum in: N Engl J Med. 2009 Nov 5;361(19):1914.

14.

Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.

Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M.

Diabetes Care. 2006 Dec;29(12):2730-2. No abstract available.

PMID:
17130215
15.

Type 1 diabetes.

Daneman D.

Lancet. 2006 Mar 11;367(9513):847-58. Review.

PMID:
16530579
16.

Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application.

Kovatchev BP, Clarke WL, Breton M, Brayman K, McCall A.

Diabetes Technol Ther. 2005 Dec;7(6):849-62.

PMID:
16386091
17.
18.

Diverse causes of hypoglycemia-associated autonomic failure in diabetes.

Cryer PE.

N Engl J Med. 2004 May 27;350(22):2272-9. Review. No abstract available.

PMID:
15163777
19.

Hypoglycemia in diabetes.

Cryer PE, Davis SN, Shamoon H.

Diabetes Care. 2003 Jun;26(6):1902-12. Review.

PMID:
12766131
20.

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.

Cryer PE.

Diabetologia. 2002 Jul;45(7):937-48. Epub 2002 Apr 26. Review.

PMID:
12136392

Supplemental Content

Support Center